Abstract
Overview
Hospital discharge forms with specific codes for rotavirus gastroenteritis in children 0 to 14 years of age were reviewed in the period 2003–2005 in the province of Ferrara.
Results
A total of 4,238 children were admitted to the pediatric departments; 151 patients were diagnosed with rotavirus gastroenteritis. The average annual rate of hospitalization for rotavirus gastroenteritis was 1.54/1,000 children <14 years of age and 2.9/1,000 children <5 years of age. Most hospitalizations (72%) involved children aged <60 months. The average length of hospital stay was about 5 days. Considering the Emilia Romagna regional reimbursement codes referable to rotavirus disease, the estimated costs of our 151 cases range from €214,033 to €341,832.
Conclusions
The results of this study contribute to the awareness of rotavirus epidemiology in Italy and underline the potential impact of rotavirus vaccination in our province.
Similar content being viewed by others
References
Araujo EC, Clemens SA, Oliveira CS et al (2007) Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy infants. J Pediatr (Rio J) 83:217–224, doi:10.2223/JPED.1600
Bernstein DI (2007) RIX4414 (Rotarix): a live attenuated human rotavirus vaccine. J Pediatr (Rio J) 83:193–195, doi:10.2223/JPED.1632
Cowden JM (2001) An estimate of the costs of cases of rotavirus infection admitted to hospital in Scotland, 1997. Health Bull (Edinb) 59:188–192
Davidson G, Elliott EJ, Kirkwood C, Pearce R (2007) Preventing rotavirus gastroenteritis: do you have the facts? J Paediatr Child Health 43:564–567, doi:10.1111/j.1440-1754.2007.01163.x
Fischer TK, Viboud C, Parashar U et al (2007) Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993–2003. J Infect Dis 195:1117–1125, doi:10.1086/512863
Forquet F, Desenclos JC, Maurage C, Baron S (2003) Acute gastroenteritis in children in France: estimates of disease burden through national hospital discharge data. Arch Pediatr 10:861–868, doi:10.1016/S0929-693X(03)00459-7
Gabutti G, Lazzara C, Marsella M et al (2007) Burden of hospitalizations attributable to rotavirus infection in Emilia Romagna, Italy. Acta Biomed 78:176–181
Gil A, Carrasco P, Jimenez R et al (2004) Burden of hospitalizations attributable to rotavirus infection in children in Spain, period 1999–2000. Vaccine 22:2221–2225, doi:10.1016/j.vaccine.2003.11.037
Glass RI, Bresee JS, Parashar U et al (2005) Rotavirus vaccines: past, present, and future. Arch Pediatr 12:844–847, doi:10.1016/j.arcped.2005.04.066
Glass RI, Parashar UD, Bresee JS et al (2006) Rotavirus vaccines: current prospects and future challenges. Lancet 368:323–332, doi:10.1016/S0140-6736(06)68815-6
Gleizes O, Desselberger U, Tatochenko V et al (2006) Nosocomial rotavirus infection in European countries. Pediatr Infect Dis J 25:S12–S21, doi:10.1097/01.inf.0000197563.03895.91
Grimwood (2007) Clinical update: rotavirus gastroenteritis and its prevention. Lancet 370:302–304
http://www.who.int/biologicals/areas/vaccines/rotavirus/background/en/index.html
Linhares AC, Villa LL (2006) Vaccines against rotavirus and human papillomavirus (HPV). J Pediatr (Rio J) 82(3):S25–S34, doi:10.2223/JPED.1492
Luquero Alcalde FJ, Eiros Bouza JM, Pérez Rubio A et al (2008) Gastroenteritis by rotavirus in Spanish children. Analysis of the disease burden. Eur J Pediatr 167:549–555 (Epub 2007 Jul 25)
Malek MA, Curns AT, Holman RC et al (2006) Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics 117:1887–1892, doi:10.1542/peds.2005-2351
Marocco A, Assael B, Gabutti G et al (2006) Ricoveri per enterite da Rotavirus in Italia valutati mediante analisi delle Schede di Dimissione Ospedaliera negli anni 2001–2003. Ig Sanita Pubbl 62:215–224
Parashar UD, Bresee JS, Gentsch JR, Glass RI (1998) Rotavirus. Emerg Infect Dis 4(4):561–570
Parashar UD, Hummelman EG, Bresee JS et al (2003) Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 9:565–572
Parashar UD, Alexander JP, Glass RI (2006) Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunisation Practices (ACIP). MMWR Morb Mortal Wkly Rep 55:1–13
PROTECT (2006) The paediatric burden of rotavirus disease in Europe. Epidemiol Infect 134:908–916, doi:10.1017/S0950268806006091
Rheingans RD, Heylen J, Giaquinto C (2006) Economics of rotavirus gastroenteritis and vaccination in Europe: What makes sense? Pediatr Infect Dis J 25:S48–S55, doi:10.1097/01.inf.0000197566.47750.3d
Ruggeri FM, Declich S (1999) RV infection among children with diarrhoea in Italy. Acta Paediatr 88(Suppl.):66–71, doi:10.1111/j.1651-2227.1999.tb14329.x
Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR et al (2006) Human Rotavirus Vaccine Study Group 2006 safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354:11–22, doi:10.1056/NEJMoa052434
Simpson R, Aliyu S, Iturriza-Gomara M et al (2003) Infantile viral gastroenteritis: on the way to closing the diagnostic gap. J Med Virol 70:258–262, doi:10.1002/jmv.10386
Soriano-Gabarro M, Mukowicz J, Vesikari T, Verstraeten T (2006) Burden on rotavirus disease in European Union countries. Pediatr Infect Dis J 25:S7–S11, doi:10.1097/01.inf.0000197622.98559.01
Stebbins S (2007) Rotavirus: disease and vaccine update. J Fam Pract 56:S6–S11
Van Damme P, Van der Wielen M, Ansaldi F et al (2006) Rotavirus vaccines: considerations for successful implementation in Europe. Lancet Infect Dis 6:805–812, doi:10.1016/S1473-3099(06)70657-0
Van Damme P, Giaquinto C, Huet F, REVEAL Study Group et al (2007) Multicenter Prospective Study of the Burden of Rotavirus Acute Gastroenteritis in Europe, 2004–2005: The REVEAL Study. J Infect Dis 195:S4–S16, doi:10.1086/516714
Velazquez FR, Matson DO, Calva JJ et al (1996) Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 335:1022–1028, doi:10.1056/NEJM199610033351404
Vesikari T, Matson DO, Dennehy P et al (2006) Rotavirus Efficacy and Safety Trial (REST) Study Team 2006 safety and efficacy of a pentavalent human–bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354:23–33, doi:10.1056/NEJMoa052664
WHO (2007) Rotavirus vaccines. Wkly Epidemiol Rec 82:285–296
Conflict of interest
The authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marsella, M., Raimondi, L., Bergamini, M. et al. Epidemiology of rotavirus-associated hospital admissions in the province of Ferrara, Italy. Eur J Pediatr 168, 1423–1427 (2009). https://doi.org/10.1007/s00431-009-0942-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-009-0942-z